Literature DB >> 23752905

Prion disease: a promising rating scale for prion disease clinical research.

Pietro Tiraboschi, Fabrizio Tagliavini.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23752905     DOI： 10.1038/nrneurol.2013.109

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

3.  PRION-1 scales analysis supports use of functional outcome measures in prion disease.

Authors:  S Mead; M Ranopa; G S Gopalakrishnan; A G B Thompson; P Rudge; S Wroe; A Kennedy; F Hudson; A MacKay; J H Darbyshire; J Collinge; A S Walker
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

4.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

5.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

Review 6.  Sporadic human prion diseases: molecular insights and diagnosis.

Authors:  Gianfranco Puoti; Alberto Bizzi; Gianluigi Forloni; Jiri G Safar; Fabrizio Tagliavini; Pierluigi Gambetti
Journal:  Lancet Neurol       Date:  2012-07       Impact factor: 44.182

7.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

8.  A new rating scale for Alzheimer's disease.

Authors:  W G Rosen; R C Mohs; K L Davis
Journal:  Am J Psychiatry       Date:  1984-11       Impact factor: 18.112

9.  Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial.

Authors:  John Collinge; Michele Gorham; Fleur Hudson; Angus Kennedy; Geraldine Keogh; Suvankar Pal; Martin Rossor; Peter Rudge; Durre Siddique; Moira Spyer; Dafydd Thomas; Sarah Walker; Tom Webb; Steve Wroe; Janet Darbyshire
Journal:  Lancet Neurol       Date:  2009-03-09       Impact factor: 44.182

10.  The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies.

Authors:  Andrew G B Thompson; Jessica Lowe; Zoe Fox; Ana Lukic; Marie-Claire Porter; Liz Ford; Michele Gorham; Gosala S Gopalakrishnan; Peter Rudge; A Sarah Walker; John Collinge; Simon Mead
Journal:  Brain       Date:  2013-04       Impact factor: 13.501
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.